Please Wait
Applying Filters...
menu
    • menu
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Sodium Arsanilate

    ACTIVE PHARMA INGREDIENTS

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Holder DMF No. Subject Submission Date Status Type GDUFA DMF Review GDUFA Review Date GDUFA Payment Date
    28/10/2024 Abbott Laboratories
    U.S.A
    		 ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV 701 ARSANILIC ACID--SODIUM ARSANILATE WITH ZOALENE (VET DMF) 1962-08-30 Inactive II N/A
    28/10/2024 Abbott Laboratories
    U.S.A
    		 ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV 488 ARSANILIC ACID (SODIUM ARSANILATE) 1962-06-12 Inactive II N/A